KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Finished Goods (2016 - 2020)

Historic Finished Goods for Amgen (AMGN) over the last 5 years, with Q1 2020 value amounting to $1.0 billion.

  • Amgen's Finished Goods rose 762.89% to $1.0 billion in Q1 2020 from the same period last year, while for Mar 2020 it was $1.0 billion, marking a year-over-year increase of 762.89%. This contributed to the annual value of $999.0 million for FY2019, which is 234.6% down from last year.
  • According to the latest figures from Q1 2020, Amgen's Finished Goods is $1.0 billion, which was up 762.89% from $999.0 million recorded in Q4 2019.
  • Over the past 5 years, Amgen's Finished Goods peaked at $1.2 billion during Q1 2017, and registered a low of $912.0 million during Q4 2016.
  • For the 5-year period, Amgen's Finished Goods averaged around $1.0 billion, with its median value being $1.0 billion (2017).
  • Examining YoY changes over the last 5 years, Amgen's Finished Goods showed a top increase of 952.89% in 2018 and a maximum decrease of 940.47% in 2018.
  • Quarter analysis of 5 years shows Amgen's Finished Goods stood at $912.0 million in 2016, then rose by 2.41% to $934.0 million in 2017, then grew by 9.53% to $1.0 billion in 2018, then dropped by 2.35% to $999.0 million in 2019, then increased by 4.5% to $1.0 billion in 2020.
  • Its Finished Goods was $1.0 billion in Q1 2020, compared to $999.0 million in Q4 2019 and $996.0 million in Q3 2019.